What is LOPJLB’s current signal on GRFS?

LOPJLB’s latest quantitative signal on Grifols, S.A. (GRFS) is SELL in a RECOVERY regime. Signals are updated daily.

What market regime is GRFS in?

Grifols, S.A. (GRFS) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does Grifols, S.A. (GRFS) do?

Grifols, S.A., a company founded in 1940 and headquartered in Barcelona, Spain, specializes in the development, manufacture, and distribution of therapeutic products, with a primary focus on those derived from human plasma. Its operations are organized into several divisions. The Bioscience division is dedicated to researching, producing, and marketing plasma-derived medicines, such as immunogl…

Where is Grifols, S.A. based / listed?

Grifols, S.A. is based in ES, listed on NASDAQ.

Grifols, S.A. (GRFS)

COMPARE

Healthcare · Drug Manufacturers - General · NASDAQ · ES

$7.46+0.67%Close

SELLRECOVERY · day 4

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $6.3B
Beta: 1.19
Div yield: 1.41%
P/E (TTM): 14.75

Short % float: 0.84%
Days to cover: 8.7
SI change: +105.0%

1W: +2.05%
1M: -2.48%

vs SPY 1W: +0.89%
vs SPY 1M: -5.48%

Industry peers

FMP comparable companies · ranked by market cap

ABTSELLAbbott Laboratories$170.4BRECOVERYQ 19$98.49+1.13%
BDXSELLBecton, Dickinson and Company$50.4BBULLQ 21$182.75+0.55%
TECHBUYBio-Techne Corporation$11.3BBULLQ 19$72.45+0.01%
BIOSELLBio-Rad Laboratories, Inc.$9.7BBULLQ 19$360.40+1.60%
HAEBUYHaemonetics Corporation$5.4BBULLQ 11$119.47-0.65%
ADMABUYADMA Biologics, Inc.$2.4BRECOVERYQ 9$10.33+0.29%
MRVIBUYMaravai LifeSciences Holdings, Inc.$2.0BCRISISQ -1$7.21+3.19%
QDELBUYQuidelOrtho Corporation$846MRECOVERYQ 8$12.41+8.14%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Industry peers

Prediction markets

Company news